Back to search
FDAFDA · Food and drugs·Recall number D-0118-2017

Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.

Published November 9, 2016 · Recall initiated: August 30, 2016

Summary

FDA records drug Class III recall D-0118-2017, published November 9, 2016 and initiated August 30, 2016. Recalling firm: Actavis Laboratories, FL, Inc.; Status: Ongoing; Reported quantity: 15,984 bottles; Lot: Lot #: 1136091A, Incorrectly Labeled Exp: 03/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis Laboratories, FL, Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 1136091A, Incorrectly Labeled Exp: 03/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30. recalled?

Yes. FDA published recall D-0118-2017 on November 9, 2016. Reported hazard: Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.

What should I do if I have this product?

Voluntary: Firm initiated · Letter